Journalartikel

REMISSIONPLUS, an Initiative to Integrate Modern Imaging into Rheumatologic Care - Review, Appraisal and Outlook: Evaluation of Low-Field MRI Data


AutorenlisteSewerin, Philipp; Klein, Sabine; Brinks, Ralph; Hoyer, Annika; Schleich, Christoph; Miese, Falk; Blaschke, Sabine; Edelmann, Edmund; Gao, Ino K.; Georgi, Joachim; Keliner, Herbert; Keysser, Gernot; Lorenz, Hanns-Martin; Mueller-Ladner, Ulf; Pott, Hans-Georg; Schulze-Koops, Hendrik; Walther, Marisa; Schmidt, Wolfgang A.; Schneider, Matthias; Ostendorf, Benedikt

Jahr der Veröffentlichung2017

Seiten432-441

ZeitschriftAktuelle Rheumatologie

Bandnummer42

Heftnummer5

ISSN0341-051X

eISSN1438-9940

Open Access StatusBronze

DOI Linkhttps://doi.org/10.1055/s-0042-124184

VerlagGeorg Thieme Verlag


Abstract
Imaging plays a vital role in the diagnosis and treatment control of rheumatoid arthritis (RA). Since 2006, the initiative REMISSIONPLUS has aimed to implement modern imaging tools like arthrosonography and magnetic resonance imaging (MRI) into the routine clinical practice of rheumatologists. In addition to training sessions (over 3000 rheumatologists in over200 sessions), numerous sonography and MRI studies have been conducted to assess the value of these techniques fortreatment control in RA. The following study summarises the results of the low-field MRI-studies. The results of this multicenter study demonstrate that low-field MRI is a comfortable examination for RA patients and enables rheumatologists to effectively and very carefully monitortreatment outcomes (DMARDs, biologics). MRI data significantly correlate with clinical and laboratory parameters. In addition, this method allows clinicians to detect subclinical indicators for arthritis as well as advancing radiological progression despite clinical remission ("silent progression"). These findings cannot be obtained in conventional X-rays. The use of MRI thus provides new insights into the pathogenesis and will consecutively deliver new informations for RA management. The assessment of these advantages and the benefits for patients in daily clinical routine need to be further examined and discussed in future studies.



Zitierstile

Harvard-ZitierstilSewerin, P., Klein, S., Brinks, R., Hoyer, A., Schleich, C., Miese, F., et al. (2017) REMISSIONPLUS, an Initiative to Integrate Modern Imaging into Rheumatologic Care - Review, Appraisal and Outlook: Evaluation of Low-Field MRI Data, Aktuelle Rheumatologie, 42(5), pp. 432-441. https://doi.org/10.1055/s-0042-124184

APA-ZitierstilSewerin, P., Klein, S., Brinks, R., Hoyer, A., Schleich, C., Miese, F., Blaschke, S., Edelmann, E., Gao, I., Georgi, J., Keliner, H., Keysser, G., Lorenz, H., Mueller-Ladner, U., Pott, H., Schulze-Koops, H., Walther, M., Schmidt, W., Schneider, M., ...Ostendorf, B. (2017). REMISSIONPLUS, an Initiative to Integrate Modern Imaging into Rheumatologic Care - Review, Appraisal and Outlook: Evaluation of Low-Field MRI Data. Aktuelle Rheumatologie. 42(5), 432-441. https://doi.org/10.1055/s-0042-124184



Schlagwörter


7-JOINT ULTRASOUND SCOREAMERICAN-COLLEGEBONE EROSIONSCLINICAL REMISSIONDEDICATED EXTREMITY MRILOW DISEASE-ACTIVITYMRIRADIOGRAPHIC PROGRESSIONRHEUMATOLOGY/EUROPEAN LEAGUESTRUCTURAL PROGRESSION


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-10-06 um 10:48